Drug recall · January 26, 2022
Mucus Relief D recall
Why: Subpotent drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3
- Lots / codes
Lot #: AT2102065A, AT2102065B, Exp 04/2023.
- Quantity
- 18336 cartons
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- USA Nationwide
- Initiated
- January 10, 2022 · Voluntary: Firm initiated
- Classified
- January 19, 2022
- Reported
- January 26, 2022
- Ended
- March 29, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Guaifenesin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.